BioXcel Therapeutics, Inc.·4

Aug 26, 5:38 PM ET

MUELLER PETER 4

4 · BioXcel Therapeutics, Inc. · Filed Aug 26, 2019

Insider Transaction Report

Form 4
Period: 2019-08-23
Transactions
  • Purchase

    Common Stock

    2019-08-23$9.34/sh+1,554$14,514168,320 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were acquired in multiple transactions at prices ranging from $9.09 to $9.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.

Documents

1 file
  • 4
    a4.xmlPrimary

    4